Acciones del sector sanitario
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1003 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.01 USD | -3.69% | -1.36% | +12.27% | +41.09% | 8.42 B USD | ||
| 1009 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 129.89 USD | -1.16% | -2.04% | +18.08% | +72.89% | 8.35 B USD | ||
| 1012 |  APGE Apogee Therapeutics, Inc. - Common Stock | 133.82 USD | +0.13% | +0.25% | +49.25% | +149.71% | 8.28 B USD | ||
| 1016 |  PCVX Vaxcyte, Inc. - Common Stock | 57.03 USD | -2.03% | -1.30% | +19.53% | +34.82% | 8.23 B USD | ||
| 1024 |  RGEN Repligen Corporation - Common Stock | 144.88 USD | +0.44% | +0.21% | +8.35% | -12.56% | 8.17 B USD | ||
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +7.76% | -1.00% | 8.00 B USD | ||
| 1035 |  ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1036 |  BIO Bio-Rad Laboratories, Inc. Class A Common Stock | 297.56 USD | +0.48% | -0.36% | +2.96% | -11.62% | 7.96 B USD | ||
| 1041 |  IMVT Immunovant, Inc. - Common Stock | 38.70 USD | -2.54% | -0.77% | +14.50% | +101.46% | 7.95 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.69% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD | ||
| 1088 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 119.04 USD | -2.53% | -3.69% | +19.65% | +69.74% | 7.26 B USD | ||
| 1120 |  LNTH Lantheus Holdings, Inc. - Common Stock | 105.39 USD | -0.24% | +3.83% | +0.59% | +88.00% | 6.86 B USD | ||
| 1122 |  PACS PACS Group, Inc. Common Stock | 43.29 USD | +0.12% | -4.12% | +16.59% | +236.89% | 6.85 B USD | ||
| 1156 |  SRRK Scholar Rock Holding Corporation - Common Stock | 54.70 USD | -3.54% | -1.48% | +22.07% | +82.21% | 6.55 B USD | ||
| 1159 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 67.72 USD | -1.74% | +10.83% | +29.88% | +66.02% | 6.55 B USD | ||
| 1161 |  CHE Chemed Corp | 492.28 USD | +0.80% | +1.43% | +17.61% | +6.45% | 6.53 B USD | ||
| 1176 |  COGT Cogent Biosciences, Inc. - Common Stock | 37.46 USD | -3.63% | -6.12% | +12.16% | +139.06% | 6.40 B USD |
Noticias Acciones del sector sanitario
S&P Global mejora perspectiva de Revvity por reducción de apalancamiento
Glencore convierte un bono convertible de 25.000 millones de dólares en Osisko Metals
Stifel inicia cobertura de Arrowhead Pharma con recomendación de compra
Dexcom recibe autorización de Health Canadá para el G7 15 Day CGM
¿Por qué cae hoy la acción de Erasca?
Astrana Health nombra ejecutivos para su área médica y transformación empresarial
Erasca planea una oferta de acciones de 500 millones de dólares para financiar su investigación
Gainers Acciones del sector sanitario
 XAIR Beyond Air, Inc. - Common Stock | 7.49 | +1683.33% |
 QTTB Q32 Bio Inc. - Common Stock | 21.38 | +90.72% |
 AGEN Agenus Inc. - Common Stock | 6.12 | +82.69% |
 SRXH SRX Health Solutions, Inc. Common Stock | 2.78 | +31.13% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.50 | +23.97% |
 TOIIW The Oncology Institute, Inc. - Warrant | 0.0597 | +19.64% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0239 | +19.50% |
 GALT Galectin Therapeutics Inc. - Common Stock | 4.60 | +13.30% |
Losers Acciones del sector sanitario
 MTNB Matinas Biopharma Holdings, Inc. Common Stock | 0.49 | -33.78% |
 AEON AEON Biopharma, Inc. Class A Common Stock | 0.32 | -33.33% |
 LUCYW Innovative Eyewear, Inc. - Warrants | 0.0537 | -29.34% |
 BIVI BioVie Inc. - Common stock | 1.64 | -27.75% |
 ZCMD Zhongchao Inc. - Class A Ordinary Shares | 1.51 | -25.62% |
 APLM Apollomics Inc. - Class A Ordinary Shares | 14.21 | -25.01% |
 HUMAW Humacyte, Inc. - Warrant | 0.0076 | -24.00% |
 AARD Aardvark Therapeutics, Inc. - Common Stock | 5.96 | -21.58% |